EGFR and non-small cell lung carcinoma: Epidermal growth factor receptor (EGFR) mutations, pivotal oncogenic drivers in NSCLC, are detected in 30%–50% of Asian and 10%–20% of Western populations (Midha et al., 2015; Shi et al., 2014).